Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

Paul L. Leong, Genevieve A. Andrews, Daniel E. Johnson, Kevin F. Dyer, Sichuan Xi, Jeffrey C. Mai, Paul D. Robbins, Seshu Gadiparthi, Nancy A. Burke, Simon F. Watkins, Jennifer Rubin Grandis

Research output: Contribution to journalArticle

273 Citations (Scopus)

Abstract

The transcription factor signal transducer and activator of transcription 3 (Stat3) is constitutively activated in a variety of cancers including squamous cell carcinoma of the head and neck (SCCHN). Previous investigations have demonstrated that activated Stat3 contributes to a loss of growth control and transformation. To investigate the therapeutic potential of blocking Stat3 in cancer cells, we developed a transcription factor decoy to selectively abrogate activated Stat3. The Stat3 decoy was composed of a 15-mer double-stranded oligonucleotide, which corresponded closely to the Stat3 response element within the c-fos promoter. The Stat3 decoy bound specifically to activated Stat3 and blocked binding of Stat3 to a radiolabeled Stat3 binding element. By contrast, a mutated version of the decoy that differed by only a single base pair did not bind the activated Stat3 protein. Treatment of head and neck cancer cells with the Stat3 decoy inhibited proliferation and Stat3-mediated gene expression, but did not decrease the proliferation of normal oral keratinocytes. Thus, disruption of activated Stat3 by using a transcription factor decoy approach may serve as a novel therapeutic strategy for cancers characterized by constitutive Stat3 activation.

Original languageEnglish (US)
Pages (from-to)4138-4143
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume100
Issue number7
DOIs
StatePublished - Apr 1 2003

Fingerprint

STAT3 Transcription Factor
Head and Neck Neoplasms
Oligonucleotides
Growth
Transcription Factors
STAT Transcription Factors
Neoplasms
Response Elements
Keratinocytes
Base Pairing

All Science Journal Classification (ASJC) codes

  • General

Cite this

Leong, Paul L. ; Andrews, Genevieve A. ; Johnson, Daniel E. ; Dyer, Kevin F. ; Xi, Sichuan ; Mai, Jeffrey C. ; Robbins, Paul D. ; Gadiparthi, Seshu ; Burke, Nancy A. ; Watkins, Simon F. ; Grandis, Jennifer Rubin. / Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. In: Proceedings of the National Academy of Sciences of the United States of America. 2003 ; Vol. 100, No. 7. pp. 4138-4143.
@article{8e9f5774c5694c98bced36dca638132c,
title = "Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth",
abstract = "The transcription factor signal transducer and activator of transcription 3 (Stat3) is constitutively activated in a variety of cancers including squamous cell carcinoma of the head and neck (SCCHN). Previous investigations have demonstrated that activated Stat3 contributes to a loss of growth control and transformation. To investigate the therapeutic potential of blocking Stat3 in cancer cells, we developed a transcription factor decoy to selectively abrogate activated Stat3. The Stat3 decoy was composed of a 15-mer double-stranded oligonucleotide, which corresponded closely to the Stat3 response element within the c-fos promoter. The Stat3 decoy bound specifically to activated Stat3 and blocked binding of Stat3 to a radiolabeled Stat3 binding element. By contrast, a mutated version of the decoy that differed by only a single base pair did not bind the activated Stat3 protein. Treatment of head and neck cancer cells with the Stat3 decoy inhibited proliferation and Stat3-mediated gene expression, but did not decrease the proliferation of normal oral keratinocytes. Thus, disruption of activated Stat3 by using a transcription factor decoy approach may serve as a novel therapeutic strategy for cancers characterized by constitutive Stat3 activation.",
author = "Leong, {Paul L.} and Andrews, {Genevieve A.} and Johnson, {Daniel E.} and Dyer, {Kevin F.} and Sichuan Xi and Mai, {Jeffrey C.} and Robbins, {Paul D.} and Seshu Gadiparthi and Burke, {Nancy A.} and Watkins, {Simon F.} and Grandis, {Jennifer Rubin}",
year = "2003",
month = "4",
day = "1",
doi = "10.1073/pnas.0534764100",
language = "English (US)",
volume = "100",
pages = "4138--4143",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "7",

}

Leong, PL, Andrews, GA, Johnson, DE, Dyer, KF, Xi, S, Mai, JC, Robbins, PD, Gadiparthi, S, Burke, NA, Watkins, SF & Grandis, JR 2003, 'Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth', Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 4138-4143. https://doi.org/10.1073/pnas.0534764100

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. / Leong, Paul L.; Andrews, Genevieve A.; Johnson, Daniel E.; Dyer, Kevin F.; Xi, Sichuan; Mai, Jeffrey C.; Robbins, Paul D.; Gadiparthi, Seshu; Burke, Nancy A.; Watkins, Simon F.; Grandis, Jennifer Rubin.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, No. 7, 01.04.2003, p. 4138-4143.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

AU - Leong, Paul L.

AU - Andrews, Genevieve A.

AU - Johnson, Daniel E.

AU - Dyer, Kevin F.

AU - Xi, Sichuan

AU - Mai, Jeffrey C.

AU - Robbins, Paul D.

AU - Gadiparthi, Seshu

AU - Burke, Nancy A.

AU - Watkins, Simon F.

AU - Grandis, Jennifer Rubin

PY - 2003/4/1

Y1 - 2003/4/1

N2 - The transcription factor signal transducer and activator of transcription 3 (Stat3) is constitutively activated in a variety of cancers including squamous cell carcinoma of the head and neck (SCCHN). Previous investigations have demonstrated that activated Stat3 contributes to a loss of growth control and transformation. To investigate the therapeutic potential of blocking Stat3 in cancer cells, we developed a transcription factor decoy to selectively abrogate activated Stat3. The Stat3 decoy was composed of a 15-mer double-stranded oligonucleotide, which corresponded closely to the Stat3 response element within the c-fos promoter. The Stat3 decoy bound specifically to activated Stat3 and blocked binding of Stat3 to a radiolabeled Stat3 binding element. By contrast, a mutated version of the decoy that differed by only a single base pair did not bind the activated Stat3 protein. Treatment of head and neck cancer cells with the Stat3 decoy inhibited proliferation and Stat3-mediated gene expression, but did not decrease the proliferation of normal oral keratinocytes. Thus, disruption of activated Stat3 by using a transcription factor decoy approach may serve as a novel therapeutic strategy for cancers characterized by constitutive Stat3 activation.

AB - The transcription factor signal transducer and activator of transcription 3 (Stat3) is constitutively activated in a variety of cancers including squamous cell carcinoma of the head and neck (SCCHN). Previous investigations have demonstrated that activated Stat3 contributes to a loss of growth control and transformation. To investigate the therapeutic potential of blocking Stat3 in cancer cells, we developed a transcription factor decoy to selectively abrogate activated Stat3. The Stat3 decoy was composed of a 15-mer double-stranded oligonucleotide, which corresponded closely to the Stat3 response element within the c-fos promoter. The Stat3 decoy bound specifically to activated Stat3 and blocked binding of Stat3 to a radiolabeled Stat3 binding element. By contrast, a mutated version of the decoy that differed by only a single base pair did not bind the activated Stat3 protein. Treatment of head and neck cancer cells with the Stat3 decoy inhibited proliferation and Stat3-mediated gene expression, but did not decrease the proliferation of normal oral keratinocytes. Thus, disruption of activated Stat3 by using a transcription factor decoy approach may serve as a novel therapeutic strategy for cancers characterized by constitutive Stat3 activation.

UR - http://www.scopus.com/inward/record.url?scp=0037386568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037386568&partnerID=8YFLogxK

U2 - 10.1073/pnas.0534764100

DO - 10.1073/pnas.0534764100

M3 - Article

C2 - 12640143

AN - SCOPUS:0037386568

VL - 100

SP - 4138

EP - 4143

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 7

ER -